Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy

Nat Commun. 2020 Oct 8;11(1):5144. doi: 10.1038/s41467-020-19083-3.

¹ Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. MACortez@mdanderson.org.
² Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁶ Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁷ Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.